Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[F18]-FDDNP-PET for Tauopathy Diagnosis in Parkinsonism
NCT02214862Phase 1Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Mar 2013
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Relative Volume of Distribution of [18F]-FDDNP at 18 months. Started Mar 2013; status: completed.
Beyond the preview
Go deeper on NCT02214862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214862.